Cargando…
Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats
BACKGROUND: Cyclosporin A (CsA) is a promising therapeutic drug for myocardial ischemia reperfusion injury (MI/RI) because of its definite inhibition to the opening of mitochondrial permeability transition pore (mPTP). However, the application of cyclosporin A to treat MI/RI is limited due to its im...
Autores principales: | Zhang, Chang-xiong, Cheng, Ying, Liu, Dao-zhou, Liu, Miao, Cui, Han, Zhang, Bang-le, Mei, Qi-bing, Zhou, Si-yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346555/ https://www.ncbi.nlm.nih.gov/pubmed/30683110 http://dx.doi.org/10.1186/s12951-019-0451-9 |
Ejemplares similares
-
Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice
por: Liu, Daozhou, et al.
Publicado: (2022) -
Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury
por: Hefler, Joshua, et al.
Publicado: (2022) -
Temporal dynamics of immune response following prolonged myocardial ischemia/reperfusion with and without cyclosporine A
por: Rusinkevich, Vitali, et al.
Publicado: (2019) -
Protective Effects of HBSP on Ischemia Reperfusion and Cyclosporine A Induced Renal Injury
por: Wu, Yuanyuan, et al.
Publicado: (2013) -
Protective Effects of Co-Administration of Gallic Acid and Cyclosporine on Rat Myocardial Morphology Against Ischemia/Reperfusion
por: Dianat, Mahin, et al.
Publicado: (2014)